The effect of adjuvant oral application of honey in the management of postoperative pain after tonsillectomy in adults: A pilot study

PLoS One. 2020 Feb 10;15(2):e0228481. doi: 10.1371/journal.pone.0228481. eCollection 2020.

Abstract

Objective: To analyze the effect of adjuvant oral application of honey for treating postoperative pain after tonsillectomy.

Design: Single centre prospective cohort study.

Setting: Two cohorts of patients after tonsillectomy.

Participants: 56 patients treated with honey 8 times per day (honey group), 18 patients treated without honey (control group); baseline analgesia were non-steroidal anti-inflammatory drugs (NSAID) or coxibs; opioids were used as pro re nata (PRN) medication; mean age 34.4 ± 13.4 years; 36% women.

Main outcome measures: On first to fifth postoperative day, patients rated their pain using the validated questionnaire of the German-wide project Quality Improvement in Postoperative Pain Treatment (QUIPS) including a numeric rating scale (NRS, 0-10) for determination of patient's pain. QUIPS allows standardized assessment of patients' characteristics andpain-associated patient-reported outcomes (PROs). The influence of preoperative and postoperative parameters on patients' postoperative pain were estimated by univariate and multivariate statistical analysis.

Results: Average pain in activity in the control group was greater than 4 (NRS 4.4 ± 2.4) during the first five postoperative days, with a renewed increase in pain intensity on the fifth day (4.3 ± 2.5). In the honey group, the pain in activity decreased without any further pain increase and was only higher than 4 on the first three postoperative days (4.3 ± 2.1, all p>0.05). However; neither minimal nor maximal pain were significantly different between both groups on the first postoperative day (p = 0.217, p = 0.980). Over the five postoperative days, the minimal and maximal pain in the honey group decreased continuously and faster than in the control group. With regard to pain-related impairments on the first day, the honey group reported less pain-related sleep disturbance (p = 0.026), as well as significantly fewer episodes of postoperative oral bleeding (p = 0.028) than the control group. Patients without honey consumption had on the first and fifth postoperative day a higher risk of increased minimal pain (OR = -2.424, CI = -4.075 --0.385). Gender was an independent factor for compliance of honey consumption on the second postoperative day (p = 0.037). Men had a lower probability for compliance of honey consumption (OR = -0.288, CI = -2.863 --0.090).

Conclusion: There was a trend of reduced postoperative pain after oral honey application. Honey also seems to reduce pain-related impairments. The need for additional opioids on the first day could be reduced. A larger controlled trial is now needed to varify the effect of honey on pain after tonsillectomy.

Clinical trial registration number: German Clinical Trials Register DRKS00006153. The authors confirm that all ongoing and related trials for this drug/intervention are registered.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Adjuvants, Pharmaceutic*
  • Administration, Oral
  • Adult
  • Analgesics, Opioid / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Cohort Studies
  • Female
  • Honey*
  • Humans
  • Male
  • Middle Aged
  • Pain Management / methods*
  • Pain Measurement
  • Pain, Postoperative / drug therapy*
  • Pilot Projects
  • Postoperative Period
  • Tonsillectomy / adverse effects*
  • Tonsillitis / drug therapy
  • Tonsillitis / surgery*
  • Young Adult

Substances

  • Adjuvants, Pharmaceutic
  • Analgesics, Opioid
  • Anti-Inflammatory Agents, Non-Steroidal

Associated data

  • DRKS/DRKS00006153

Grants and funding

The authors received no specific funding for this work.